Cargando…

Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome

Cannabis is one of the most widely used illicit drugs in the world. Its use is associated with several short- and long-term side-effects such as changes in mood, impaired memory, impaired attention, depression and anxiety, and it is correlated with schizophrenia. Cannabinoid hyperemesis syndrome (CH...

Descripción completa

Detalles Bibliográficos
Autores principales: Attout, Hassene, Amichi, Sofia, Josse, Françoise, Appavoupoule, Vincent, Randriajohany, Andry, Thirapathi, Yogananda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213821/
https://www.ncbi.nlm.nih.gov/pubmed/32399447
http://dx.doi.org/10.12890/2020_001588
_version_ 1783531859417759744
author Attout, Hassene
Amichi, Sofia
Josse, Françoise
Appavoupoule, Vincent
Randriajohany, Andry
Thirapathi, Yogananda
author_facet Attout, Hassene
Amichi, Sofia
Josse, Françoise
Appavoupoule, Vincent
Randriajohany, Andry
Thirapathi, Yogananda
author_sort Attout, Hassene
collection PubMed
description Cannabis is one of the most widely used illicit drugs in the world. Its use is associated with several short- and long-term side-effects such as changes in mood, impaired memory, impaired attention, depression and anxiety, and it is correlated with schizophrenia. Cannabinoid hyperemesis syndrome (CHS) is characterized by chronic cannabis use, cyclic intractable nausea and vomiting, and compulsive hot bathing. Patients are typically diagnosed with CHS only after multiple medical evaluations. Recent research has identified type 1 cannabinoid receptors in the intestinal nerve plexus that have an inhibitory effect on gastrointestinal motility. This effect may explain hyperemesis in cannabis users. The thermoregulatory role of endocannabinoids may be responsible for compulsive hot bathing. We describe the cases of two young men seeking repeated emergency room care with recurrent nausea and vomiting. Abstinence from cannabis led to resolution of vomiting symptoms and abdominal pain. LEARNING POINTS: Cannabis is one of the most widely used illicit drugs in world. Cannabinoid hyperemesis syndrome is an under-recognized syndrome that can lead to expensive and unrevealing investigations. Abstinence from cannabis led to resolution of symptoms.
format Online
Article
Text
id pubmed-7213821
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SMC Media Srl
record_format MEDLINE/PubMed
spelling pubmed-72138212020-05-12 Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome Attout, Hassene Amichi, Sofia Josse, Françoise Appavoupoule, Vincent Randriajohany, Andry Thirapathi, Yogananda Eur J Case Rep Intern Med Articles Cannabis is one of the most widely used illicit drugs in the world. Its use is associated with several short- and long-term side-effects such as changes in mood, impaired memory, impaired attention, depression and anxiety, and it is correlated with schizophrenia. Cannabinoid hyperemesis syndrome (CHS) is characterized by chronic cannabis use, cyclic intractable nausea and vomiting, and compulsive hot bathing. Patients are typically diagnosed with CHS only after multiple medical evaluations. Recent research has identified type 1 cannabinoid receptors in the intestinal nerve plexus that have an inhibitory effect on gastrointestinal motility. This effect may explain hyperemesis in cannabis users. The thermoregulatory role of endocannabinoids may be responsible for compulsive hot bathing. We describe the cases of two young men seeking repeated emergency room care with recurrent nausea and vomiting. Abstinence from cannabis led to resolution of vomiting symptoms and abdominal pain. LEARNING POINTS: Cannabis is one of the most widely used illicit drugs in world. Cannabinoid hyperemesis syndrome is an under-recognized syndrome that can lead to expensive and unrevealing investigations. Abstinence from cannabis led to resolution of symptoms. SMC Media Srl 2020-03-27 /pmc/articles/PMC7213821/ /pubmed/32399447 http://dx.doi.org/10.12890/2020_001588 Text en © EFIM 2020 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Articles
Attout, Hassene
Amichi, Sofia
Josse, Françoise
Appavoupoule, Vincent
Randriajohany, Andry
Thirapathi, Yogananda
Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome
title Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome
title_full Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome
title_fullStr Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome
title_full_unstemmed Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome
title_short Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome
title_sort cannabis hyperemesis syndrome: a still under-recognized syndrome
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213821/
https://www.ncbi.nlm.nih.gov/pubmed/32399447
http://dx.doi.org/10.12890/2020_001588
work_keys_str_mv AT attouthassene cannabishyperemesissyndromeastillunderrecognizedsyndrome
AT amichisofia cannabishyperemesissyndromeastillunderrecognizedsyndrome
AT jossefrancoise cannabishyperemesissyndromeastillunderrecognizedsyndrome
AT appavoupoulevincent cannabishyperemesissyndromeastillunderrecognizedsyndrome
AT randriajohanyandry cannabishyperemesissyndromeastillunderrecognizedsyndrome
AT thirapathiyogananda cannabishyperemesissyndromeastillunderrecognizedsyndrome